Skip to content

DIADEMA PARTNERS LP

Follow

13F filer, CIK 2026172, MORRISTOWN, NJ

DIADEMA PARTNERS LP reported $780,451,639 across 148 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 63.06% of the portfolio.

Accepted , ingested 13F-HR 0001892688-26-000170

Period
2026-09-30
Reported value
$780M
Holdings
148
Top 10 weight
63.06%
New
58
Sold out
59

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BBIOnew+103,960$6.84M
COGTadded+148,283$4.75M
REPLnew+305,000$4.04M
LQDAnew+120,000$3.63M
MBXnew+60,000$3.52M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KODreduced-179,126-$17M
RVMDreduced-69,214-$14.2M
EWTXreduced-227,868-$9.25M
NVOexited-100,000-$4.81M
RLAYexited-230,677-$4.32M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001892688-26-000170, largest first. % of portfolio is the value over $269,218,273, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,000 shares; 2026Q1: 27,303 shares; 2026Q2: 52,989 shares; 2026Q3: 46,222 shares 46,222$25M9.3%-6,767Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 90,000 shares; 2025Q1: 392,213 shares; 2025Q2: 392,213 shares; 2025Q3: 97,813 shares; 2025Q4: 131,852 shares; 2026Q1: 322,764 shares; 2026Q2: 493,664 shares; 2026Q3: 641,947 shares 641,947$20.6M7.64%+148,283Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,620 shares; 2025Q4: 75,644 shares; 2026Q1: 75,944 shares; 2026Q2: 163,644 shares; 2026Q3: 178,444 shares 178,444$17.7M6.59%+14,800Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 52,877 shares; 2025Q2: 192,877 shares; 2025Q3: 212,877 shares; 2025Q4: 146,361 shares; 2026Q1: 148,229 shares; 2026Q2: 312,846 shares; 2026Q3: 255,383 shares 255,383$15.3M5.69%-57,463Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 79,079 shares; 2025Q3: 59,079 shares; 2025Q4: 37,020 shares; 2026Q1: 80,872 shares; 2026Q2: 139,218 shares; 2026Q3: 70,004 shares 70,004$14.4M5.34%-69,214Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 104,121 shares; 2025Q2: 197,468 shares; 2025Q3: 193,689 shares; 2025Q4: 336,849 shares; 2026Q1: 525,181 shares; 2026Q2: 441,808 shares; 2026Q3: 433,166 shares 433,166$14.1M5.25%-8,642Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 85,311 shares; 2026Q2: not reported; 2026Q3: 103,960 shares 103,960$6.84M2.54%newTimeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 96,984 shares; 2025Q2: 104,384 shares; 2025Q3: 124,384 shares; 2025Q4: 70,300 shares; 2026Q1: 193,189 shares; 2026Q2: 254,863 shares; 2026Q3: 221,764 shares 221,764$6.72M2.5%-33,099Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 571,107 shares; 2026Q3: 421,107 shares 421,107$6.03M2.24%-150,000Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 49,478 shares; 2025Q1: 162,063 shares; 2025Q2: 122,061 shares; 2025Q3: not reported; 2025Q4: 21,114 shares; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 257,076 shares 257,076$5.29M1.97%+157,076Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 66,444 shares; 2026Q1: 53,771 shares; 2026Q2: 22,000 shares; 2026Q3: 17,000 shares 17,000$4.5M1.67%-5,000Timeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 71,376 shares; 2026Q2: 67,512 shares; 2026Q3: 117,512 shares 117,512$4.21M1.56%+50,000Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 92,385 shares; 2025Q2: 198,285 shares; 2025Q3: 218,285 shares; 2025Q4: 22,972 shares; 2026Q1: 25,071 shares; 2026Q2: 45,071 shares; 2026Q3: 72,850 shares 72,850$4.15M1.54%+27,779Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 114,000 shares; 2025Q1: 74,530 shares; 2025Q2: 32,483 shares; 2025Q3: not reported; 2025Q4: 230,997 shares; 2026Q1: 100,660 shares; 2026Q2: not reported; 2026Q3: 305,000 shares 305,000$4.04M1.5%newTimeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 165,965 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 238,142 shares; 2026Q2: 223,810 shares; 2026Q3: 153,810 shares 153,810$3.97M1.48%-70,000Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 192,962 shares; 2026Q2: 218,117 shares; 2026Q3: 38,991 shares 38,991$3.7M1.37%-179,126Timeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,881 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 120,000 shares 120,000$3.63M1.35%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 60,000 shares 60,000$3.52M1.31%newTimeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 75,000 shares; 2025Q1: 50,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 30,000 shares 30,000$2.86M1.06%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 29,321 shares; 2026Q2: 29,321 shares; 2026Q3: 90,000 shares 90,000$2.85M1.06%+60,679Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 181,947 shares 181,947$2.79M1.04%newTimeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 244,811 shares; 2026Q2: 294,811 shares; 2026Q3: 204,811 shares 204,811$2.36M0.88%-90,000Timeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 212,475 shares; 2025Q4: 302,000 shares; 2026Q1: 186,603 shares; 2026Q2: 16,003 shares; 2026Q3: 604,025 shares 604,025$2.36M0.88%+588,022Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 56,337 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 18,497 shares 18,497$2.11M0.78%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 190,928 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$2.08M0.77%newTimeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 334,251 shares; 2026Q1: 352,399 shares; 2026Q2: 740,786 shares; 2026Q3: 553,126 shares 553,126$2.06M0.77%-187,660Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 522,619 shares; 2026Q3: 422,619 shares 422,619$2.06M0.76%-100,000Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares; 2026Q2: 30,000 shares; 2026Q3: 40,435 shares 40,435$1.96M0.73%+10,435Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,359 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: not reported; 2026Q2: 272,214 shares; 2026Q3: 44,346 shares 44,346$1.8M0.67%-227,868Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,539 shares; 2026Q1: not reported; 2026Q2: 149,482 shares; 2026Q3: 208,167 shares 208,167$1.74M0.65%+58,685Timeline
PTHSPELTHOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,498 shares; 2025Q4: 25,000 shares; 2026Q1: 24,773 shares; 2026Q2: 24,773 shares; 2026Q3: 80,760 shares 80,760$1.7M0.63%+55,987Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 53,152 shares 53,152$1.55M0.57%newTimeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 476,424 shares; 2026Q2: 462,724 shares; 2026Q3: 398,869 shares 398,869$1.47M0.55%-63,855Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 158,023 shares; 2025Q1: 207,694 shares; 2025Q2: 157,694 shares; 2025Q3: 157,694 shares; 2025Q4: 167,532 shares; 2026Q1: 180,083 shares; 2026Q2: 926,016 shares; 2026Q3: 826,286 shares 826,286$1.37M0.51%-99,730Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 389,395 shares; 2026Q1: 200,842 shares; 2026Q2: 361,367 shares; 2026Q3: 361,367 shares 361,367$1.36M0.51%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 40,294 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 54,650 shares; 2026Q2: 129,950 shares; 2026Q3: 179,950 shares 179,950$1.31M0.49%+50,000Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 91,259 shares 91,259$1.28M0.48%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 26,347 shares; 2026Q2: 56,347 shares; 2026Q3: 50,000 shares 50,000$1.26M0.47%-6,347Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 57,608 shares; 2026Q3: 38,008 shares 38,008$1.23M0.46%-19,600Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.17M0.43%newTimeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 27,799 shares; 2026Q3: 13,169 shares 13,169$1.1M0.41%-14,630Timeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 600,000 shares; 2026Q2: 374,403 shares; 2026Q3: 262,059 shares 262,059$1.01M0.38%-112,344Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 35,271 shares 35,271$874K0.32%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 119,733 shares; 2026Q3: 64,549 shares 64,549$866K0.32%-55,184Timeline
ADILADIAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 181,890 shares 181,890$729K0.27%newTimeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 23,260 shares; 2026Q2: 23,260 shares; 2026Q3: 245,098 shares 245,098$713K0.26%+221,838Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 932 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 60,000 shares; 2026Q3: 41,887 shares 41,887$708K0.26%-18,113Timeline
NBPNOVABRIDGE BIOSCIENCESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000$682K0.25%newTimeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 146,446 shares 146,446$668K0.25%newTimeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 43,972 shares 43,972$649K0.24%newTimeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$635K0.24%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,000 shares 25,000$624K0.23%newTimeline
SLSSELLAS LIFE SCIENCES GROUP IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$616K0.23%newTimeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,800 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 166,637 shares; 2026Q2: 146,637 shares; 2026Q3: 185,705 shares 185,705$593K0.22%+39,068Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 135,000 shares 135,000$540K0.2%newTimeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 121,539 shares; 2026Q3: 21,539 shares 21,539$511K0.19%-100,000Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 133,385 shares 133,385$494K0.18%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 245 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$458K0.17%0Timeline
TLPHTALPHERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 136,923 shares; 2026Q1: 153,563 shares; 2026Q2: 153,563 shares; 2026Q3: 378,037 shares 378,037$439K0.16%+224,474Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000$372K0.14%newTimeline
AEMDAETHLON MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$326K0.12%newTimeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 51,117 shares 51,117$268K0.1%newTimeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 252,198 shares; 2026Q1: not reported; 2026Q2: 303,025 shares; 2026Q3: 77,133 shares 77,133$264K0.1%-225,892Timeline
OCGNOCUGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000$206K0.08%0Timeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 9,700 shares 9,700$166K0.06%newTimeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 17,587 shares 17,587$154K0.06%newTimeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 458,723 shares; 2026Q3: 458,723 shares 458,723$144K0.05%0Timeline
AYTUAYTU BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 272,670 shares; 2025Q4: 305,788 shares; 2026Q1: 353,077 shares; 2026Q2: 148,546 shares; 2026Q3: 67,186 shares 67,186$144K0.05%-81,360Timeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 9,021 shares; 2026Q3: 12,174 shares 12,174$137K0.05%+3,153Timeline
CLRBCELLECTAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 138,341 shares; 2026Q3: 71,382 shares 71,382$131K0.05%-66,959Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 166,049 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 69,533 shares 69,533$93.9K0.03%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 36,500 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,000 shares; 2026Q1: 31,200 shares; 2026Q2: not reported; 2026Q3: 3,400 shares 3,400$82.1K0.03%newTimeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 65,138 shares; 2026Q1: 64,952 shares; 2026Q2: not reported; 2026Q3: 5,503 shares 5,503$72.5K0.03%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 19,302 shares; 2025Q2: 14,816 shares; 2025Q3: not reported; 2025Q4: 2,000 shares; 2026Q1: 6,000 shares; 2026Q2: not reported; 2026Q3: 60 shares 60$69.4K0.03%newTimeline
TVRDTVARDI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,185 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 16,607 shares; 2026Q3: 48,491 shares 48,491$60.6K0.02%+31,884Timeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 44,907 shares; 2026Q3: 28,872 shares 28,872$21.7K0.01%-16,035Timeline
OTLKOUTLOOK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 35,000 shares 35,000$20.1K0.01%newTimeline
ELTXELICIO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 9,440 shares 9,440$17.2K0.01%newTimeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 194 shares 194$11.3K<0.01%newTimeline
MXCTMAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,190 shares 8,190$9.17K<0.01%newTimeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 124 shares 124$1.5K<0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
VKTXVIKING THERAPEUTICS INC COMput1,361,900$44.4M+1,011,400
BMYBRISTOL-MYERS SQUIBB CO COMcall600,000$37.4M0
VKTXVIKING THERAPEUTICS INC COMcall1,139,400$37.1M-81,400
KODKODIAK SCIENCES INC COMput297,000$28.2M+150,100
UTHRUNITED THERAPEUTICS CORP DEL Stockcall47,500$25.7Mnew
BNTXBIONTECH SE ADRcall250,000$24.6M+150,000
KODKODIAK SCIENCES INC COMcall251,700$23.9M+55,000
BMYBRISTOL-MYERS SQUIBB CO COMput330,600$20.6M0
GMABGENMAB A/S Ordinary Shares, nominal value DKK 1 per sharecall518,100$18.5Mnew
KYMRKYMERA THERAPEUTICS INC COMcall160,900$18M+11,200
SMMTSUMMIT THERAPEUTICS INC COMcall960,200$16.2M+100,000
NVSNOVARTIS AG ADRput100,000$14.3M0
GRALGRAIL INC COMcall100,000$14Mnew
ABVXABIVAX SA SPONSORED ADSput137,700$13.6M-114,700
SMMTSUMMIT THERAPEUTICS INC COMput801,400$13.6M+601,400
INCYINCYTE CORP Stockput105,400$12.8M0
CORTCORCEPT THERAPEUTICS INC COMcall100,000$11.5M-106,300
ABVXABIVAX SA SPONSORED ADScall114,600$11.3M-234,600
PCVXVAXCYTE INC Stockput197,800$11.3M+148,900
PCVXVAXCYTE INC Stockcall153,100$8.71M+100,000
MRNAMODERNA INC COMcall44,400$8.55Mnew
XBISPDR SERIES TRUST S&P BIOTECHput50,000$7.88Mnew
LQDALIQUIDIA CORPORATION Stockcall257,200$7.78Mnew
QUREUNIQURE NV SHScall235,400$5.69M0
CRBPCORBUS PHARMACEUTICALS HLDGS COM NEWcall800,000$5.46M+166,200
QUREUNIQURE NV SHSput199,300$4.82M-99,700
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKcall497,300$4.71M+168,000
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKput484,400$4.59M-50,000
LQDALIQUIDIA CORPORATION Stockput150,000$4.54Mnew
BHVNBIOHAVEN LTD COMcall317,000$4.23M0
VORVOR BIOPHARMA INC COMMON STOCKcall200,000$3.82Mnew
ABSIABSCI CORPORATION COMcall304,200$3.28Mnew
RCUSARCUS BIOSCIENCES INC COMcall124,100$3.21M+100
COGTCOGENT BIOSCIENCES INC COMcall100,000$3.2Mnew
PHVSPHARVARIS N V COMMON STOCKput100,000$3.17Mnew
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput250,000$3.08M+150,000
IMCRIMMUNOCORE HLDGS PLC ADRcall100,000$3.03Mnew
IOVAIOVANCE BIOTHERAPEUTICS INC COMcall200,000$2.96Mnew
SLSSELLAS LIFE SCIENCES GROUP I COM NEWcall200,000$2.46M-200,000
NTLAINTELLIA THERAPEUTICS INC COMcall200,000$2.41M0
ADMAADMA BIOLOGICS INC COMcall200,000$2.01M0
VSTMVERASTEM INC COMMON STOCKcall200,000$1.61Mnew
CELCCELCUITY INC COMcall20,000$1.59M0
CRVSCORVUS PHARMACEUTICALS INC COMcall133,400$1.54M0
ALMSALUMIS INC COMcall200,000$1.48M0
ABCLABCELLERA BIOLOGICS INC Stockcall100,000$1.46Mnew
ARQTARCUTIS BIOTHERAPEUTICS INC COMcall50,000$1.32Mnew
EDITEDITAS MEDICINE INC COMcall400,000$1.03M0
CTNMCONTINEUM THERAPEUTICS INC Stockcall70,000$939Knew
UNCYUNICYCIVE THERAPEUTICS INC COMMON STOCKcall192,600$904K-600,000
TYRATYRA BIOSCIENCES INC COMMON STOCKput30,000$656Knew
VYGRVOYAGER THERAPEUTICS INC COMMON STOCKcall150,000$402K0
MNKDMANNKIND CORP Stockcall102,500$400Knew
INOINOVIO PHARMACEUTICALS INC COMMON STOCKcall275,200$336K0
ANNXANNEXON INC COMcall50,000$212K-303,200
PYXSPYXIS ONCOLOGY INC Stockcall88,200$206K-300,000
GANXGAIN THERAPEUTICS INC COMcall108,200$187Knew
ELTXELICIO THERAPEUTICS INC LST Equity Optionput100,000$182K0
ALDXALDEYRA THERAPEUTICS INC COMcall88,500$109Knew
CMPXCOMPASS THERAPEUTICS INC COMcall50,000$52Knew
ELTXELICIO THERAPEUTICS INC LST Equity Optioncall6,500$11.8K-105,600
MGTXMEIRAGTX HLDGS PLC COMMON STOCKcall500$5.5K0
ATYRATYR PHARMA INC COM NEWput12,500$3.79K0
JBIOJADE BIOSCIENCES INC COM NEWput1,046$2.93K0
REPLREPLIMUNE GROUP INC COMMON STOCKput200$2.65K-502,300

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
VIKING THERAPEUTICS INCVIKING THERAPEUTICS INC NOTE 2.000%10/1principal1,000,000$32.6Mnew
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 1.750% 3/0principal250,000$16.4M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BIIBBIOGEN INC60,000$13Mcall
LLYELI LILLY & CO10,000$12Mput
NVSNOVARTIS AG50,000$7.84Mcall
REPLREPLIMUNE GROUP INC696,300$7.71Mcall
MRNAMODERNA INC100,000$7Mput
HIMSHIMS & HERS HEALTH INC200,000$6.93Mcall
HIMSHIMS & HERS HEALTH INC193,700$6.72Mput
RPRXROYALTY PHARMA PLC100,000$5.61Mcall
BIOABIOAGE LABS INC200,100$4.9Mcall
NVONOVO-NORDISK A S100,000$4.81Mshares
TENXTENAX THERAPEUTICS INC307,000$4.47Mcall
RLAYRELAY THERAPEUTICS INC230,677$4.32Mshares
TGTXTG THERAPEUTICS INC75,700$4.16Mcall
GLUEMONTE ROSA THERAPEUTICS INC170,100$4.12Mcall
ZYMEZYMEWORKS INC142,132$3.72Mshares
AMGNAMGEN INC10,000$3.62Mcall
BIOABIOAGE LABS INC146,334$3.59Mshares
CLDXCELLDEX THERAPEUTICS INC NEW86,000$3.2Mput
CRBPCORBUS PHARMACEUTICALS HLDGS301,264$2.83Mshares
NVONOVO-NORDISK A S55,900$2.68Mput
CYTKCYTOKINETICS INC30,000$2.56Mput
VERAVERA THERAPEUTICS INC50,000$2.15Mput
SEPNSEPTERNA INC59,700$2Mput
GLUEMONTE ROSA THERAPEUTICS INC78,391$1.9Mshares
CLDXCELLDEX THERAPEUTICS INC NEW50,900$1.89Mcall
CUECUE BIOPHARMA INC48,369$1.53Mshares
EYPTEYEPOINT INC106,300$1.52Mcall
VYGRVOYAGER THERAPEUTICS INC413,642$1.45Mshares
UNCYUNICYCIVE THERAPEUTICS INC303,676$1.42Mshares
EOLSEVOLUS INC200,000$1.39Mcall
SYRESPYRE THERAPEUTICS INC15,000$1.33Mshares
HELPCYBIN INC200,000$1.32Mshares
CRMDCORMEDIX INC167,500$1.31Mput
EQEQUILLIUM INC400,282$1.28Mshares
XERSXERIS BIOPHARMA HOLDINGS INC132,746$1.05Mshares
HRMYHARMONY BIOSCIENCES HLDGS IN26,864$978Kshares
RNACCARTESIAN THERAPEUTICS INC87,057$907Kshares
AQSTAQUESTIVE THERAPEUTICS INC214,600$893Kcall
RIGLRIGEL PHARMACEUTICALS INC22,816$893Kshares
PGENPRECIGEN INC135,293$771Kshares
DFTXDEFINIUM THERAPEUTICS INC15,451$727Kshares
PEPGPEPGEN INC373,284$672Kshares
HELPCYBIN INC100,000$661Kcall
CGONCG ONCOLOGY INC7,300$519Kcall
CNTBCONNECT BIOPHARMA HLDGS LTD196,985$469Kshares
FHTXFOGHORN THERAPEUTICS INC66,908$327Kshares
URGNUROGEN PHARMA LTD7,137$263Kshares
AMGNAMGEN INC102,701$215Kshares
ANNXANNEXON INC27,516$157Kshares
MNPRMONOPAR THERAPEUTICS INC1,630$151Kshares
LAKELAKELAND INDS INC14,108$151Kshares
UPBUPSTREAM BIO INC19,093$132Kshares
MGTXMEIRAGTX HLDGS PLC8,368$113Kshares
KLRAKAILERA THERAPEUTICS INC3,621$79.8Kshares
SPRYARS PHARMACEUTICALS INC4,860$38.9Kshares
VTGNVISTAGEN THERAPEUTICS INC57,700$13Kcall
NXTCNEXTCURE INC7,742$12.4Kshares
ERASERASCA INC100$1.83Kcall
CUECUE BIOPHARMA INC6$6call

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001892688-26-000170 base2026-11-16